Reinier de Graaf Groep — Sponsor Intelligence | 2 EU Trials

Filter these 2 trials by condition, phase, country and more.

2 Registered trials

2 Recruiting

0 Completed trials

1 Countries active

12 Unique IMPs

N/A Results reported

Phase III

Phase IV

Top indications

2 total

The RED FLASH study Recruiting

2023-507847-13-00 Phase III 1 country
EASYlight study Recruiting

2023-508417-16-00 Phase IV 1 country ESKETAMINE HYDROCHLORIDE; ONDANSETRON

Showing 1–2 of 2 trials